Highlights
- Abhishek Bhargava is appointed Group CEO of Futura Medtech.
- He brings nearly two decades of leadership experience in healthcare and medtech.
- He leads Dolphin Sutures, Suture Planet and Rivarp Medical into the group’s next phase of growth.
Bengaluru, 2 September 2026: Futura Medtech, the Bengaluru medical devices group behind Dolphin Sutures, Suture Planet and Rivarp Medical, has appointed Abhishek Bhargava as Group Chief Executive Officer.
Abhishek brings nearly two decades of experience in the healthcare and medtech industry. He has held leadership roles across leading global healthcare organisations, with expertise in business transformation, strategic growth and managing complex, multi-therapy medtech businesses.
Leading the next phase of growth
As Group CEO, Abhishek leads Futura Medtech in its next phase of growth and transformation: strengthening the group’s diversified medtech platform and shaping the future of its businesses, Dolphin Sutures, Suture Planet and Rivarp Medical.
“True progress in healthcare comes from collaboration, compassion, and continuous learning. At Futura, we are committed to that journey every day,” said Abhishek Bhargava, Group CEO, Futura Medtech.
About Futura Medtech
Futura Medtech is a Bengaluru-based medical devices group and the group brand of Futura Surgicare Pvt Ltd. Founded in 1994, the group brings together Dolphin Sutures, Suture Planet and Rivarp Medical, covering wound closure, hernia repair, ligation, hemostasis, spine, interventional cardiology and neuromonitoring. Its products are supplied to hospitals, governments and distributors in more than 85 countries.
Media contact
hello@futuramedtech.com · +91 80 4080 2850



